Abediterol is an investigational drug.
There have been 4 clinical trials for Abediterol.
The most recent clinical trial was a Phase 1 trial, which was initiated on January 28th 2020.
The most common disease conditions in clinical trials are Pulmonary Disease, Chronic Obstructive, Lung Diseases, Obstructive, and Lung Diseases. The leading clinical trial sponsors are AstraZeneca, Parexel, and [disabled in preview].
There are one hundred and thirty-one US patents protecting this investigational drug and one international patent.